Lycia Therapeutics Inc. LYCA · News

website

Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the disco...

Price30.36

Market Cap1.75 B

Float18.24 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

FEATURED

Lycia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SOUTH SAN FRANCISCO, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. ("Lycia") (NASDAQ:LYCA), a clinical-stage biotechnology company focused on the discovery and development of novel

Summary

Oct 26, 2026, 4:12 PM ·Globe Newswire

RECENT

Lycia Therapeutics Announces Pricing of Upsized Initial Public Offering

SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. ("Lycia") (NASDAQ:LYCA), a clinical-stage biotechnology company focused on the discovery and development of novel

Oct 22, 2026, 7:51 PM ·Globe Newswire